KBC Group
RGNX icon

KBC Group’s Regenxbio RGNX Stock Holding History

KBC Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,801
Closed -$38K – 1906
2024
Q1 		$38K Hold
1,801
– – ﹤0.01% 1690
2023
Q4 		$32K Hold
1,801
– – ﹤0.01% 1780
2023
Q3 		$30K Sell
1,801
-1,048
-37% -$19K ﹤0.01% 1784
2023
Q2 		$57K Hold
2,849
– – ﹤0.01% 1338
2023
Q1 		$54K Hold
2,849
– – ﹤0.01% 1366
2022
Q4 		$65K Hold
2,849
– – ﹤0.01% 1334
2022
Q3 		$75K Sell
2,849
-772
-21% -$22.9K ﹤0.01% 1289
2022
Q2 		$89K Hold
3,621
– – ﹤0.01% 1272
2022
Q1 		$120K Buy
3,621
+2,270
+168% +$63.1K ﹤0.01% 1140
2021
Q4 		$44K Hold
1,351
– – ﹤0.01% 1255
2021
Q3 		$57K Sell
1,351
-360
-21% -$13K ﹤0.01% 1226
2021
Q2 		$66K Buy
1,711
+1,351
+375% +$48.3K ﹤0.01% 1209
2021
Q1 		$12K Hold
360
– – ﹤0.01% 1281
2020
Q4 		$16K Hold
360
– – ﹤0.01% 1256
2020
Q3 		$10K Hold
360
– – ﹤0.01% 1220
2020
Q2 		$13K Hold
360
– – ﹤0.01% 1259
2020
Q1 		$12K Hold
360
– – ﹤0.01% 1267
2019
Q4 		$15K Sell
360
-10
-3% -$395 ﹤0.01% 1470
2019
Q3 		$13K Sell
370
-10,552
-97% -$428K ﹤0.01% 1457
2019
Q2 		$561K Hold
10,922
– – ﹤0.01% 1031
2019
Q1 		$626K Buy
+10,922
New +$541K 0.01% 1017
2018
Q3 		– Sell
-4,840
Closed -$347K – 1413
2018
Q2 		$347K Buy
+4,840
New +$231K ﹤0.01% 1069

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

KBC Group's RGNX Position: Q2 2024 in Review

KBC Group sold out of Regenxbio (RGNX) in Q2 2024, closing a stake of 1,801 shares — an estimated $38K sold.

KBC Group first reported a position in RGNX in Q2 2018 and held it in 22 quarters. The position peaked at $626K in Q1 2019. 181 funds tracked by Wall St. Rank hold RGNX as of Q2 2024.

  • KBC Group reported no remaining Regenxbio position as of Q2 2024 after selling out during the quarter.
  • KBC Group sold 1,801 Regenxbio shares in Q2 2024, an estimated $38K.
  • KBC Group first reported a position in Regenxbio in Q2 2018 and held it in 22 quarters.
  • KBC Group's Regenxbio position peaked at $626K in Q1 2019.
  • 181 funds tracked by Wall St. Rank held Regenxbio as of Q2 2024.

Based on KBC Group's 13F filing for Q2 2024, filed 17 Jul 2024.